Risk grade updatedRisk gradeEvidence verified
4 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.Business profile
Avansor Pharma Oy
Avansor Pharma Oy's registered office is Esbo. It is a limited company. The company was established on 2003-06-19. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €3,267,178 and operating profit was €17,862.
Business ID 1835834-2ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 1835834-2
- Sector
- Wholesale of pharmaceutical goods
- Municipality
- Esbo
- Company form
- Limited company
- Registration date
- 2003-06-19
- Business ID registration date
- 2003-06-06
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Tekniikantie 14, 02150, Esbo
Phone: +358504666881Source observation
Email: [email protected]Source observation
Website: https://www.avansorpharma.fiSource observation
Linkedin profile: https://www.linkedin.com/company/avansor-pharma-oySource: company website
People and decision-makers
Lindroos Carl-Johan ErikToimitusjohtaja
About Avansor Pharma Oy
Financial position and key figures for the company.
Avansor Pharma Oy's location municipality is Esbo. It is a limited company. The company was established on 2003-06-19. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €3,267,178 and operating profit was €17,862. The latest retained financial statement for 2025-12-31 shows revenue of €3,267,178 and profit for the financial year of -€95,626. Based on the latest retained statement, revenue growth was -17.0%, operating margin was +0.6%, and equity ratio was +78.8%.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2025-12-31
0
0
Enriched source observation
Derived indicators
Revenue growth-17.0%
Operating margin0.6%
Equity ratio78.8%
Revenue€3,267,178-€671,292 (-17.0%) vs previous periodPrevious: €3,938,470
Operating profit (loss)€17,862-€1,526,187 (-98.8%) vs previous periodPrevious: €1,544,049
Profit (loss) for the financial year-€95,626-€1,189,945 (-108.7%) vs previous periodPrevious: €1,094,319
Assets€6,199,314-€477,353 (-7.1%) vs previous periodPrevious: €6,676,668
Balance-sheet contextLatest financial period
Profit before taxes€52,296Previous: €1,560,170
Employees2Previous: 2
Revenue trend4 periods
€2,752,880
2022-12-31
€2,973,768
2023-12-31
€3,938,470
2024-12-31
€3,267,178
2025-12-31
Operating profit (loss) trend4 periods
€194,634
2022-12-31
€253,371
2023-12-31
€1,544,049
2024-12-31
€17,862
2025-12-31
Profit (loss) for the financial year trend4 periods
€149,251
2022-12-31
€174,129
2023-12-31
€1,094,319
2024-12-31
-€95,626
2025-12-31
Assets trend4 periods
€4,506,185
2022-12-31
€5,080,013
2023-12-31
€6,676,668
2024-12-31
€6,199,314
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.
Equity ratioGood
98/100 · Improving
Current ratioNot assessable
0/100 · Trend unavailable
Operating profit marginPassable
51/100 · Declining
Ratio history
| Ratio | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Equity ratio | 91.2 % | 82.3 % | 76.8 % | 78.8 % |
| Current ratio | - | - | - | - |
| Operating profit margin | 7.0 % | 8.5 % | 38.4 % | 0.6 % |
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID1835834-2
VAT IDFI18358342
EU IDFIFPRO.1835834-2
MunicipalityEsbo
Current registered entries
2003-06-06Registered in Tax Administration (Prepayment Register)
2003-06-17Registered in Tax Administration (Tax Administration)
2003-06-19Registered in Patent and Registration Office (Trade Register)
2003-08-01VAT-liable for business activity in Tax Administration (VAT Register)
2006-03-01Registered in Tax Administration (Employer Register)
Responsible people
Public role relationships materialized from source observations.
Lindroos Carl-Johan ErikToimitusjohtajaSources: 4 · Confidence: 78%
Lindroos Hans GunnarPuheenjohtajaSources: 4 · Confidence: 78%
Lindroos Eva MariaProkuristiSources: 1 · Confidence: 78%
Lindroos Carl-Johan ErikVarsinainen jäsenSources: 1 · Confidence: 72%
Eva LindroosHallitus: varajäsenSources: 1 · Confidence: 76%
Juha HeikkolaPäävastuullinen tilintarkastajaSources: 1 · Confidence: 76%
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
B1
StableAvansor Pharma Oy
69/100
Medium
Strong financial evidenceFinancial data included
Financial development has been volatile across multiple domains.
4 comparable periodsRevenueVolatile
ProfitabilityVolatile
LiquidityNot enough history
National Tier 1 comparisonDescriptive comparison – does not change the model score.
263 peersSolvency65%
Better than 65% of peers
Profitability40%
Below 60% of peers
Revenue growth16%
Below 84% of peers
Supporting factors
- Strong equity ratio
- Active registered status
- Long registry continuity
Risk factors to note
- Negative profitability or net result
- Material volatility across multiple financial domains
- Elevated industry distress context
B1
2026-10-04
open-risk-grade-v0.14
The grade can use open digital financial statement data together with registry signals.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry riskelevated
45/100
Industry context is elevated based on normalized open statistical inputs.
Age and continuityVakiintunut
80/100
The company has about 23 years of registry continuity.
Registry and status signalsVakaa
88/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Registry timeline
Trade register notifications shown on a timeline.
31 register eventsLatest event: 2025-08-16
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
Avansor Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.